<SEC-DOCUMENT>0001193125-21-171149.txt : 20210525
<SEC-HEADER>0001193125-21-171149.hdr.sgml : 20210525
<ACCEPTANCE-DATETIME>20210524174402
ACCESSION NUMBER:		0001193125-21-171149
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20210524
ITEM INFORMATION:		Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210525
DATE AS OF CHANGE:		20210524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
		CENTRAL INDEX KEY:			0000885590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14956
		FILM NUMBER:		21956475

	BUSINESS ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8
		BUSINESS PHONE:		514-744-6792

	MAIL ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
		DATE OF NAME CHANGE:	20100928

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL Corp
		DATE OF NAME CHANGE:	20100416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
		DATE OF NAME CHANGE:	19960522
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d189409d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhc="http://www.bauschhealth.com/20210524" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:srt-types="http://fasb.org/srt/2020-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2021-05-24_to_2021-05-24" name="dei:EntityCentralIndexKey" contextRef="duration_2021-05-24_to_2021-05-24">0000885590</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_DocumentFiscalYearFocus_duration_2021-05-24_to_2021-05-24" name="dei:DocumentFiscalYearFocus" contextRef="duration_2021-05-24_to_2021-05-24">2020</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_DocumentFiscalPeriodFocus_duration_2021-05-24_to_2021-05-24" name="dei:DocumentFiscalPeriodFocus" contextRef="duration_2021-05-24_to_2021-05-24">FY</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2021-05-24_to_2021-05-24" name="dei:AmendmentFlag" contextRef="duration_2021-05-24_to_2021-05-24">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="bhc-20210524.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-05-24_to_2021-05-24"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885590</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-05-24</xbrli:startDate> <xbrli:endDate>2021-05-24</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-05-24_to_2021-05-24">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of the earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-05-24_to_2021-05-24" format="ixt:datemonthdayyearen">May 24, 2021</ix:nonNumeric> (May 24, 2021)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityRegistrantName">Bausch Health Companies Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen">British Columbia</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen">Canada</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityFileNumber">001-14956</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityTaxIdentificationNumber">98-0448205</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction of</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Incorporation or Organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr> </table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityAddressAddressLine1">2150 St. Elz&#233;ar Blvd. West</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityAddressCityOrTown">Laval</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen">Quebec</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2021-05-24_to_2021-05-24" format="ixt-sec:countrynameen">Canada</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-05-24_to_2021-05-24">H7L 4A8</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices)(Zip Code)</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-05-24_to_2021-05-24">514</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-05-24_to_2021-05-24">744-6792</ix:nonNumeric></span></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-05-24_to_2021-05-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-05-24_to_2021-05-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-05-24_to_2021-05-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2021-05-24_to_2021-05-24" name="dei:PreCommencementIssuerTenderOffer" format="ixt:booleanfalse">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-05-24_to_2021-05-24">Common Shares, No Par Value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-05-24_to_2021-05-24">BHC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-05-24_to_2021-05-24" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric>, Toronto Stock Exchange</span></td></tr> </table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-05-24_to_2021-05-24" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;2.04.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Triggering Event That Accelerates or Increases a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 24, 2021, Bausch Health Companies Inc. (the &#8220;Company&#8221;) issued a conditional notice of redemption to redeem in full all of its 7.00% Senior Secured Notes due 2024 (the &#8220;2024 Notes&#8221;) that remain outstanding following the consummation of the Tender Offer (as defined below). The redemption is expected to occur on June 23, 2021 (the &#8220;Redemption Date&#8221;), subject to satisfaction or waiver by the Company of the Condition (as defined below). The 2024 Notes were issued under an indenture dated as of March&#160;21, 2017, by and among the Company, the guarantors signatory thereto, The Bank of New York Mellon, as trustee and the Notes Collateral Agent, as supplemented and amended (the &#8220;Indenture&#8221;). The 2024 Notes will be redeemed pursuant to Article 3 of the Indenture if the Condition is satisfied or waived. The redemption price for the 2024 Notes will be $1,017.50 per $1,000 principal amount, plus accrued and unpaid interest to, but not including, the Redemption Date.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The redemption of the 2024 Notes is conditioned upon the completion by the Company or its subsidiaries of one or more debt financings in an aggregate principal amount of at least $1.6&#160;billion (the &#8220;Condition&#8221;), which the Company expects to satisfy upon closing of the offering of the Notes (as defined below). Any such financings are subject to market and other conditions.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing is qualified by reference to the press release that is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K,&#160;which</span> is incorporated herein by reference.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Secured Notes Offering </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 24, 2021, Bausch Health Companies Inc. (the &#8220;Company&#8221;) announced that it has launched and priced an offering of $1.6&#160;billion aggregate principal amount of its 4.875% Senior Secured Notes due 2028 (the &#8220;Notes&#8221;). The offering price for the Notes was 100.000% of the principal amount thereof. The Notes will be offered in the United States to qualified institutional investors pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and outside the United States to <span style="white-space:nowrap">non-U.S.</span> persons pursuant to Regulation S under the Securities Act.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company also issued press releases pursuant to Rule 135c under the Securities Act relating to the offering of the Notes. In accordance with Rule 135c(d) under the Securities Act, copies of the press releases are attached hereto as Exhibits 99.1 and 99.2 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> which are incorporated herein by reference.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing is qualified by reference to the press releases that are attached as Exhibits 99.1 and 99.2 to this Current Report on Form <span style="white-space:nowrap">8-K,</span> which are incorporated herein by reference.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> and the press releases attached hereto as Exhibits 99.1 and 99.2 do not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. These securities will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.</p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Tender Offer </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;24, 2021, the Company also announced the launch of an offer to purchase for cash any and all of its outstanding 2024 Notes (the &#8220;Tender Offer&#8221;). The Tender Offer is being made only pursuant to the Offer to Purchase, dated May&#160;24, 2021 (the &#8220;Offer to Purchase&#8221;), which more fully sets forth the terms and conditions of the Tender Offer. The Offer to Purchase does not constitute a notice of redemption of the 2024 Notes.</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Tender Offer will expire at 11:59 p.m., New York City time, on June&#160;21, 2021 (unless extended), and tendered 2024 Notes may be withdrawn at or prior to, but not after, 5:00 p.m., New York City time, on June&#160;7, 2021 (unless extended). The foregoing is qualified by reference to the press release that is attached as Exhibit 99.3 to this Current Report on Form <span style="white-space:nowrap">8-K,&#160;which</span> is incorporated herein by reference.</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; font-size:8pt; font-family:Times New Roman;font-weight:bold">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Press release announcing the launch of the Notes offering and the conditional redemption of the 2024 Notes, dated May 24, 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Press release announcing the pricing of the Notes offering, dated May 24, 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Press release announcing the launch of the Tender Offer, dated May&#160;24, 2021</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page from this Current Report on Form <span style="white-space:nowrap">8-K,</span> formatted in Inline XBRL.</td></tr></table></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT INDEX</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; font-size:8pt; font-family:Times New Roman;font-weight:bold">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d189409dex991.htm">Press release announcing the launch of the Notes offering and conditional redemption of the 2024 notes, dated May 24, 2021 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d189409dex992.htm">Press release announcing the pricing of the Notes offering, dated May 24, 2021 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d189409dex993.htm">Press release announcing the launch of the Tender Offer, dated May&#160;24, 2021 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page from this Current Report on Form <span style="white-space:nowrap">8-K,</span> formatted in Inline XBRL.</td></tr></table></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signatures</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0">
<tr>
<td style="width:44%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">BAUSCH HEALTH COMPANIES INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Paul S. Herendeen</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Paul S. Herendeen</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Executive Vice President, Chief Financial Officer</td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May 24, 2021</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d189409dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g189409g0524205019997.jpg" ALT="LOGO">
 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>Media Contact:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arthur Shannon</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Lainie Keller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>arthur.shannon@bauschhealth.com</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><U>lainie.keller@bauschhealth.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(514) <FONT STYLE="white-space:nowrap">856-3855</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(908) <FONT STYLE="white-space:nowrap">927-1198</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(877) <FONT STYLE="white-space:nowrap">281-6642</FONT> (toll free)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH ANNOUNCES LAUNCH OF PRIVATE OFFERING OF SENIOR SECURED NOTES AND CONDITIONAL REDEMPTION OF
EXISTING SENIOR SECURED NOTES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LAVAL, Quebec, May&nbsp;24, 2021 &#151; Bausch Health Companies Inc. (NYSE/TSX: BHC) (&#147;Bausch Health&#148; or the
&#147;Company&#148;) announced today that it has launched an offering of $1.6&nbsp;billion aggregate principal amount of new senior secured notes due 2028 (the &#147;Notes&#148;). The proceeds from the offering of the Notes, along with cash on hand,
are expected to be used to fund the repurchase of $1.6&nbsp;billion aggregate principal amount of the Company&#146;s existing 7.00% Senior Secured Notes due 2024 (the &#147;2024 Notes&#148;) pursuant to the Company&#146;s concurrently announced
tender offer (the &#147;Tender Offer&#148;) and to pay related fees, premiums and expenses. This announcement does not constitute an offer to purchase or the solicitation of an offer to sell the 2024 Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will be guaranteed by each of the Company&#146;s subsidiaries that are guarantors under the Company&#146;s credit agreement and existing senior
notes and will be secured on a first priority basis by liens on the assets that secure the Company&#146;s credit agreement and existing senior secured notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will not be registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or any state securities law and may not be
offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in the United States only to persons reasonably believed
to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> persons pursuant to Regulation S under the Securities Act. The Notes have not been
and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a basis, which is exempt from the prospectus requirements of such
securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also announced that it intends to issue a conditional notice of redemption today to redeem the full aggregate principal
amount of 2024 Notes that remain outstanding following the consummation of the Tender Offer. This announcement does not constitute an offer to purchase or notice of redemption with respect to the 2024 Notes. The Tender Offer is subject to and
conditioned upon the satisfaction or waiver of certain conditions described in the offer to purchase related to the Tender Offer, including the completion of the offering of the Notes. The Redemption is conditioned upon the completion by the Company
or its subsidiaries of one or more debt financings in an aggregate principal amount of at least $1.6&nbsp;billion (the &#147;Condition&#148;), which the Company expects to satisfy upon closing of the offering of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the conditional notice of redemption with respect to the 2024 Notes will be issued to the record holders of the 2024 Notes. Payment of the
redemption price and surrender of the 2024 Notes for redemption will be made through the facilities of the Depository Trust Company in accordance with the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable procedures of the Depository Trust Company on June&nbsp;23, 2021, unless no 2024 Notes remain outstanding following the consummation of the Tender Offer or the Condition is not
satisfied. If the Condition is not satisfied, the redemption date will be delayed until the Condition is satisfied. The name and address of the paying agent are as follows: The Bank of New York Mellon Trust Company, N.A., c/o The Bank of New York
Mellon; 111 Sanders Creek Parkway, East Syracuse, N.Y. 13057; Attn: Redemption Unit; Tel: (800) <FONT STYLE="white-space:nowrap">254-</FONT> 2826. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
foregoing transactions are subject to market and other conditions and are anticipated to close in the second quarter of 2021. However, there can be no assurance that the Company will be able to successfully complete the transactions, on the terms
described above, or at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release is being issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer to sell or
the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Bausch Health </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people&#146;s lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> products, primarily in the therapeutic areas of eye health, gastroenterology and
dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains forward-looking information and statements, within the meaning of applicable securities laws (collectively,
&#147;forward-looking statements&#148;), including, but not limited to, our financing plans and details thereof, including the proposed use of proceeds therefrom, our ability to close the offering of the Notes and the other expected effects of the
offering of the Notes, and the Tender Offer, the details thereof and other expected effects of the Tender Offer. Forward-looking statements may generally be identified by the use of the words &#147;anticipates,&#148; &#147;expects,&#148;
&#147;intends,&#148; &#147;plans,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;potential,&#148; &#147;target,&#148; or &#147;continue&#148; and variations or
similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in these
forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in the Company&#146;s most recent annual and quarterly reports and detailed from time to time in the Company&#146;s
other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which risks and uncertainties are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties
relating to the Company&#146;s proposed plan to separate its eye health business from the remainder of Bausch Health, including the expected benefits and costs of the separation transaction, the expected timing of completion of the separation
transaction and its terms, the Company&#146;s ability to complete the separation transaction considering the various conditions to the completion of the separation transaction (some of which are outside the Company&#146;s control, including
conditions related to regulatory matters and a possible shareholder vote, if applicable), that market or other conditions are no longer favorable to completing the transaction, that any shareholder, stock exchange, regulatory or other approval (if
required) is not obtained on the terms or timelines anticipated or at all, business disruption during the pendency of or following the separation transaction, diversion of management </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2&nbsp;|&nbsp;</B>Page<B> </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time on separation transaction-related issues, retention of existing management team members, the reaction of customers and other parties to the separation transaction, the qualification of the
separation transaction as a <FONT STYLE="white-space:nowrap">tax-free</FONT> transaction for Canadian and/or U.S. federal income tax purposes (including whether or not an advance ruling from either or both of the Canada Revenue Agency and the
Internal Revenue Service will be sought or obtained), potential <FONT STYLE="white-space:nowrap">dis-synergy</FONT> costs between the separated entity and the remainder of Bausch Health, the impact of the separation, including the leverage of Bausch
Health and the eye health business after the separation, transaction on relationships with customers, suppliers, employees and other business counterparties, general economic conditions, conditions in the markets Bausch Health is engaged in,
behavior of customers, suppliers and competitors, technological developments and legal and regulatory rules affecting Bausch Health&#146;s business. In particular, the Company can offer no assurance that any separation transaction will occur at all,
or that any separation transaction will occur on the terms and timelines anticipated by the Company. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the fear of that pandemic, the availability and effectiveness of vaccines for <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and the potential effects of that pandemic, the severity,
duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines,
employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Readers
are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to
reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3&nbsp;|&nbsp;</B>Page<B> </B></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d189409dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g189409g96g40.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Media Contact:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arthur Shannon</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lainie Keller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>arthur.shannon@bauschhealth.com</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>lainie.keller@bauschhealth.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(514) <FONT STYLE="white-space:nowrap">856-3855</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(908) <FONT STYLE="white-space:nowrap">927-1198</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(877) <FONT STYLE="white-space:nowrap">281-6642</FONT> (toll free)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH ANNOUNCES PRICING OF PRIVATE OFFERING OF SENIOR SECURED NOTES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LAVAL, Quebec, May&nbsp;24, 2021 &#151; Bausch Health Companies Inc. (NYSE/TSX: BHC) (&#147;Bausch Health&#148; or the &#147;Company&#148;) announced today
that it has priced its previously announced offering of $1.6&nbsp;billion aggregate principal amount of 4.875% senior secured notes due 2028 (the &#147;Notes&#148;). The Notes will be sold to investors at a price of 100.000% of the principal amount
thereof. The proceeds from the offering of the Notes, along with cash on hand, are expected to be used to fund the Company&#146;s offer to purchase (the &#147;Tender Offer&#148;) any and all of its outstanding 7.00% Senior Secured Notes due 2024
(the &#147;2024 Notes&#148;) and to pay related fees, premiums and expenses. If, following the consummation of the Tender Offer, any of the 2024 Notes remain outstanding, the Company will use the remaining net proceeds of the offering of the Notes
to redeem such 2024 Notes (the &#147;Redemption&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will be guaranteed by each of the Company&#146;s subsidiaries that are guarantors under
the Company&#146;s credit agreement and existing senior notes and will be secured on a first priority basis by liens on the assets that secure the Company&#146;s credit agreement and existing senior secured notes. Consummation of the offering of the
Notes is subject to various closing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will not be registered under the Securities Act of 1933, as amended (the &#147;Securities
Act&#148;), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in
the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> persons pursuant to
Regulation S under the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the Notes in Canada will be made on a
basis, which is exempt from the prospectus requirements of such securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This announcement does not constitute an offer to purchase or notice of
redemption with respect to the 2024 Notes. The Tender Offer is subject to, and conditioned upon, the satisfaction or waiver of certain conditions described in the offer to purchase related to the Tender Offer, including the completion of the
offering of the Notes. The Redemption is conditioned upon the completion by the Company or its subsidiaries of one or more debt financings in an aggregate principal amount of at least $1.6&nbsp;billion, which the Company expects to satisfy upon
closing of the offering of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release is being issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer
to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Bausch Health </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people&#146;s lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> products, primarily in the therapeutic areas of eye health, gastroenterology and
dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release contains forward-looking information and statements, within the meaning of applicable securities laws (collectively,
&#147;forward-looking statements&#148;), including, but not limited to, our financing plans and details thereof, including the proposed use of proceeds therefrom, our ability to close the offering of the Notes and the other expected effects of the
offering of the Notes, and the Tender Offer, the details thereof and other expected effects of the Tender Offer. Forward-looking statements may generally be identified by the use of the words &#147;anticipates,&#148; &#147;expects,&#148;
&#147;intends,&#148; &#147;plans,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;potential,&#148; &#147;target,&#148; or &#147;continue&#148; and variations or
similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in these
forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in the Company&#146;s most recent annual and quarterly reports and detailed from time to time in the Company&#146;s
other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which risks and uncertainties are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties
relating to the Company&#146;s proposed plan to separate its eye health business from the remainder of Bausch Health, including the expected benefits and costs of the separation transaction, the expected timing of completion of the separation
transaction and its terms, the Company&#146;s ability to complete the separation transaction considering the various conditions to the completion of the separation transaction (some of which are outside the Company&#146;s control, including
conditions related to regulatory matters and a possible shareholder vote, if applicable), that market or other conditions are no longer favorable to completing the transaction, that any shareholder, stock exchange, regulatory or other approval (if
required) is not obtained on the terms or timelines anticipated or at all, business disruption during the pendency of or following the separation transaction, diversion of management time on separation transaction-related issues, retention of
existing management team members, the reaction of customers and other parties to the separation transaction, the qualification of the separation transaction as a <FONT STYLE="white-space:nowrap">tax-free</FONT> transaction for Canadian and/or U.S.
federal income tax purposes (including whether or not an advance ruling from either or both of the Canada Revenue Agency and the Internal Revenue Service will be sought or obtained), potential <FONT STYLE="white-space:nowrap">dis-synergy</FONT>
costs between the separated entity and the remainder of Bausch Health, the impact of the separation, including the leverage of Bausch Health and of the eye health business after the separation, transaction on relationships with customers, suppliers,
employees and other business counterparties, general economic conditions, conditions in the markets Bausch Health is engaged in, behavior of customers, suppliers and competitors, technological developments and legal and regulatory rules affecting
Bausch Health&#146;s business. In particular, the Company can offer no assurance that any separation transaction will occur at all, or that any separation transaction will occur on the terms and timelines anticipated by the Company. They also
include, but are not limited to, risks and uncertainties caused by or relating to the evolving <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the fear of that pandemic, the availability and effectiveness of vaccines for <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> and the potential effects of that pandemic, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company,
including but not limited to its supply chain, third-party suppliers, project development timelines, employee base, liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease). </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2&nbsp;|&nbsp;</B>Page<B> </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Readers are cautioned not to place undue reliance on any of these forward-looking statements. These
forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual
outcomes, unless required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3&nbsp;|&nbsp;</B>Page<B> </B></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>d189409dex993.htm
<DESCRIPTION>EX-99.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.3 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g189409g0524205323738.jpg" ALT="LOGO">
 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Investor Contact:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><B>Media Contact:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arthur Shannon</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Lainie Keller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>arthur.shannon@bauschhealth.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><U>lainie.keller@bauschhealth.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(514) <FONT STYLE="white-space:nowrap">856-3855</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(908) <FONT STYLE="white-space:nowrap">927-1198</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(877) <FONT STYLE="white-space:nowrap">281-6642</FONT> (toll free)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH COMMENCES CASH TENDER OFFER FOR ANY AND ALL OF ITS 7.00% SENIOR SECURED NOTES DUE 2024
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LAVAL, Quebec, May 24, 2021 &#150; Bausch Health Companies Inc. (NYSE/TSX: BHC) (&#147;Bausch Health,&#148; the &#147;Company&#148; or the
&#147;Offeror&#148;) announced today that it has commenced a cash tender offer (the &#147;Tender Offer&#148;) to purchase any and all of its outstanding 7.00% Senior Secured Notes due 2024 (the &#147;Notes&#148;). The terms and conditions of the
Tender Offer are described in an Offer to Purchase dated May 24, 2021 (as it may be amended or supplemented from time to time, the &#147;Offer to Purchase&#148;). </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain terms of the Tender Offer: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Series&nbsp;of&nbsp;Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>144A</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CUSIP/ISIN<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Reg S</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CUSIP/ISIN</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Principal</B><br><B>Amount</B><br><B>Outstanding<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Tender&nbsp;Offer</B><br><B>Consideration<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Early</B><br><B>Tender</B><br><B>Premium<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Consideration<SUP STYLE="font-size:85%; vertical-align:top">(2)(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bausch Health Companies Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.00% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Notes&nbsp;Due&nbsp;2024</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91911K&nbsp;AK8</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">US91911KAK88</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">C94143 AK7&nbsp;/USC94143AK73</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,600,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">989.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,019.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of May&nbsp;24, 2021, there was $1.7&nbsp;billion aggregate principal amount of the Notes outstanding. The
amount above gives effect to the redemption of $100&nbsp;million aggregate principal amount of the Notes on June&nbsp;2, 2021 pursuant to the Offeror&#146;s previously announced partial redemption of the Notes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Per $1,000 principal amount of Notes validly tendered and accepted for purchase in the Tender Offer (exclusive
of any Accrued Interest, which will be paid by the Offeror in addition to the Tender Offer Consideration or the Total Consideration, as applicable, to, but not including, the applicable Settlement Date). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the Early Tender Premium. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Tender Offer will expire at 11:59 p.m., New York City time, on June 21, 2021 (such date and time, as it may be extended, the &#147;Expiration Date&#148;).
No tenders will be valid if submitted after the Expiration Date. Tendered Notes may be withdrawn from the Tender Offer at or prior to, but not after, 5:00 p.m., New York City time, on June&nbsp;7, 2021 (such date and time, as it may be extended, the
&#147;Withdrawal Deadline&#148;). Holders of Notes who tender their Notes after the Withdrawal Deadline, but prior to the Expiration Date, may not withdraw their tendered Notes, except for certain limited circumstances where additional withdrawal
rights are required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions of the Tender Offer, the consideration for each $1,000 principal amount of Notes validly
tendered (and not validly withdrawn) and accepted for purchase pursuant to the Tender Offer will be the tender offer consideration for the Notes set forth in the table above (the &#147;Tender Offer Consideration&#148;). Holders of Notes that are
validly tendered (and not validly withdrawn) at or prior to 5:00 p.m., New York City time, on June&nbsp;7, 2021 (such date and time, as it may be extended, the &#147;Early Tender Date&#148;)<B> </B>and accepted for purchase pursuant to the Tender
Offer will receive the Tender Offer Consideration plus the early tender premium, if any, for the Notes as set forth in the table above (the &#147;Early Tender Premium&#148; and, together with the Tender Offer Consideration, the &#147;Total
Consideration&#148;) on the Early Settlement Date (as defined below), which is currently expected to be June&nbsp;8, 2021. Holders of Notes validly tendered after the Early Tender Date, but at or prior to the Expiration
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Date, and accepted for purchase pursuant to the Tender Offer will receive the Tender Offer Consideration, but not the Early Tender Premium for the Notes. No tenders will be valid if submitted
after the Expiration Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the Tender Offer Consideration or the Total Consideration, as applicable, all Holders of Notes accepted for
purchase pursuant to the Tender Offer will, on the Early Settlement Date or the Final Settlement Date (as defined below), as applicable, also receive accrued and unpaid interest on the Notes from the last interest payment date to, but not including,
the Early Settlement Date or the Final Settlement Date, as applicable (the &#147;Accrued Interest&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, following the consummation of the Tender
Offer, any Notes remain outstanding, the Company will redeem the outstanding Notes on June&nbsp;23, 2021, in accordance with the terms of the Notes and the indenture governing the Notes, pursuant to a conditional notice of redemption to be issued by
the Company today. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Offeror reserves the right, in its sole discretion, at any point following the Early Tender Date and prior to the Expiration Date,
to accept for purchase any Notes validly tendered (and not validly withdrawn) at or prior to the Early Tender Date (the date of such acceptance and purchase, the &#147;Early Settlement Date&#148;). The Early Settlement Date will be determined at the
Offeror&#146;s option, assuming the conditions to the Tender Offer have been either satisfied or waived by the Offeror at or prior to the Early Settlement Date. If the Offeror elects to have an Early Settlement Date, it will accept Notes validly
tendered at or prior to the Early Tender Date. Irrespective of whether the Offeror chooses to exercise its option to have an Early Settlement Date, it will purchase any remaining Notes that have been validly tendered at or prior to the Expiration
Date and accepted for purchase, subject to all conditions to the Tender Offer having been either satisfied or waived by the Offeror, promptly following the Expiration Date (the date of such acceptance and purchase, the &#147;Final Settlement
Date&#148;; the Final Settlement Date and the Early Settlement Date each being a &#147;Settlement Date&#148;). The Final Settlement Date is expected to occur on the second business day following the Expiration Date, assuming the conditions to the
Tender Offer have been either satisfied or waived by the Offeror at or prior to the Expiration Date and all outstanding Notes are not purchased on the Early Settlement Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Tender Offer is subject to, and conditioned upon, the satisfaction or waiver of certain conditions described in the Offer to Purchase, including the
completion of the Company&#146;s concurrently announced private offering of $1.6&nbsp;billion aggregate principal amount senior secured notes, on terms acceptable to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC is acting as the dealer manager in the Tender Offer. Global Bondholder Services Corporation has been retained to serve as
both the depositary and the information agent for the Tender Offer. Persons with questions regarding the Tender Offer should contact Goldman Sachs&nbsp;&amp; Co. LLC at (collect) (212) <FONT STYLE="white-space:nowrap">902-5962</FONT> or (toll free)
(800) <FONT STYLE="white-space:nowrap">828-3182.</FONT> Requests for copies of the Offer to Purchase and other related materials should be directed to Global Bondholder Services Corporation at (toll-free) (866)
<FONT STYLE="white-space:nowrap">470-3800</FONT> or (collect) (212) <FONT STYLE="white-space:nowrap">430-3774.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of the Offeror, its board of
directors or officers, the dealer manager, the depositary, the information agent or the trustee with respect to the Notes, or any of their respective affiliates, makes any recommendation that holders tender or refrain from tendering all or any
portion of the principal amount of their Notes, and no one has been authorized by any of them to make such a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2&nbsp;|&nbsp;</B>Page<B> </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recommendation. Holders must make their own decision as to whether to tender their Notes and, if so, the principal amount of Notes to tender. The Tender Offer is made only by the Offer to
Purchase. This news release is neither an offer to purchase nor a solicitation of an offer to sell any notes in the Tender Offer. The Tender Offer is not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof
would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the Tender Offer is required to be made by a licensed broker or dealer, the Tender Offer will be deemed to be made on behalf of
the Offeror by the dealer managers or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any securities
issued pursuant to the financing transactions described above will not be registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or any state securities law and may not be offered or sold in the United States
absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. Such securities have not been and will not be qualified for sale to the public by prospectus under applicable Canadian
securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news release is being issued pursuant to Rule 135c under the Securities Act and shall not constitute an offer to sell or the solicitation of an offer to
sell or the solicitation of an offer to buy any securities that may be issued pursuant to the financing transactions described above. Further, nothing contained herein shall constitute a notice of redemption of the Notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Bausch Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve people&#146;s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing
global health. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news
release may contain forward-looking statements, within the meaning of applicable securities laws (collectively, &#147;forward looking statements&#148;) including, but not limited to, the Tender Offer, the details thereof and other expected effects
of the Tender Offer and the proposed private offering of senior secured notes and the use of proceeds therefrom. Forward-looking statements may generally be identified by the use of the words &#147;anticipates,&#148; &#147;expects,&#148;
&#147;intends,&#148; &#147;plans,&#148; &#147;should,&#148; &#147;could,&#148; &#147;would,&#148; &#147;may,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;potential,&#148; &#147;target,&#148; or &#147;continue&#148; and variations or
similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in these
forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in the Company&#146;s most recent annual and quarterly reports and detailed from time to time in the Company&#146;s
other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which risks and uncertainties are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties
relating to the Company&#146;s proposed plan to separate its eye health business from the remainder of Bausch Health, including the expected benefits and costs of the separation transaction, the expected timing of completion of the separation
transaction and its terms, the Company&#146;s ability to complete the separation transaction considering the various conditions to the completion of the separation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3&nbsp;|&nbsp;</B>Page<B> </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transaction (some of which are outside the Company&#146;s control, including conditions related to regulatory matters and a possible shareholder vote, if applicable), that market or other
conditions are no longer favorable to completing the transaction, that any shareholder, stock exchange, regulatory or other approval (if required) is not obtained on the terms or timelines anticipated or at all, business disruption during the
pendency of or following the separation transaction, diversion of management time on separation transaction-related issues, retention of existing management team members, the reaction of customers and other parties to the separation transaction, the
qualification of the separation transaction as a <FONT STYLE="white-space:nowrap">tax-free</FONT> transaction for Canadian and/or U.S. federal income tax purposes (including whether or not an advance ruling from either or both of the Canada Revenue
Agency and the Internal Revenue Service will be sought or obtained), potential <FONT STYLE="white-space:nowrap">dis-synergy</FONT> costs between the separated entity and the remainder of Bausch Health, the impact of the separation, including the
leverage of Bausch Health and the eye health business after the separation, transaction on relationships with customers, suppliers, employees and other business counterparties, general economic conditions, conditions in the markets Bausch Health is
engaged in, behavior of customers, suppliers and competitors, technological developments and legal and regulatory rules affecting Bausch Health&#146;s business. In particular, the Company can offer no assurance that any separation transaction will
occur at all, or that any separation transaction will occur on the terms and timelines anticipated by the Company. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the fear of that pandemic, the availability and effectiveness of vaccines for <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and the potential effects of that pandemic, the severity, duration
and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third-party suppliers, project development timelines, employee base,
liquidity, stock price, financial condition and costs (which may increase) and revenue and margins (both of which may decrease). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Readers are cautioned
not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect actual outcomes, unless required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4&nbsp;|&nbsp;</B>Page<B> </B></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bhc-20210524.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.3 -->
<!-- Creation date: 5/24/2021 5:09:30 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:bhc="http://www.bauschhealth.com/20210524"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.bauschhealth.com/20210524"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20210524_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20210524_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bhc-20210524_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.3 -->
<!-- Creation date: 5/24/2021 5:09:30 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bhc-20210524_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 67.3 -->
<!-- Creation date: 5/24/2021 5:09:30 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bhc-20210524.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="23.901" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="23.931" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="24.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="24.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g189409g0524205019997.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g189409g0524205019997.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  X ,D# 2(  A$! Q$!_\0
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8 !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g189409g0524205323738.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g189409g0524205323738.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  X ,D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#Q5OB-XNN=;NM/T^*"=XYI%2-806VJQ'\JF'Q0\2Z+?QQ:]IJ!"-S(4V-M]
M1VKE]'CUB7QW>)H,BQZ@9KC:S' V[CFG^*X=:M==LW\7[[@%>!&X^:,'D ]N
MM,1[KJ^M0:7X;N=8)S''!YJ9_B)'RC\217F'A?XHZO>>([&TU5K?[)._E,43
M:58\*<_7%6/BIX@@D\/Z1IEB<0W<:W1 [1 ?(/S/_CM<-K?]CKH>A_V9=![Z
M&(B[PN#O)W Y]B2/RH ]:^)/BO4_"\.FMIQB!N'D#^8F[H%Q_.M72=<O+SX>
M)K<I3[8;*2<X7Y=P!(X_"O-OB#K U_P?X7U+.7?S5E]I %##\P:[+0+F$?!D
M.95"IITRL<]#AACZYH R/!?Q&U'4AJUQK)B-M8V?VC$28).>E94'COQOXCN)
MWT2T011<E(XPVT'H"3WK+^&]M9W,/B&'49A!9R6"Q2RDX";FP#^=/TSPUXFT
MZ:XF\+ZI#=QJ0'>UE'/IE30!UG@GXBW^I:Z-$UR%$N7+*DBKM(=>JL/P-5_%
MGQ/O8-9DTKP_"CM$_E-,5WEW[A1['BL_PEXQU"/Q?#I.O6<#SR3>493$%ECD
M/3)[_P#UZQOAQY7_  LF+[5C?F?;O_YZ<_KUH T8OB;XKT>]C76;0/&W)CDB
M\MB/8BNF\;>/;O3=)T34=$>(PZ@KN3(F> %P/J,FM'XAR>%XX;#_ (2.*60E
MV\D0_>''.<=NE<!XZ?3'\)>&&T=)4T_=<^4LOWOO+G]<T >M:-JES?>"[75)
MMOVF2S\YL# W;<]*Y'X;^-M7\4:K=V^HF$QQ6XD7RTVG.X"N+T\^/?[%@^R?
M;?[+\D;-N-OE8_EBJND?VF)W_P"$2\S[5M_>_9^OE]L^V:UA2YH2G=:&%2OR
M5(T^5OFZ]%ZGT/6'H6K7&HZGK-O,$V6=QY<>T<XYZ_E5+P%_;W]@R_\ "0^=
M]L^T-M\[KLPN/PSFL;3&UM?$'B#^R([=U^UGS/-..<G&*NA34X3O;9;^IEBJ
MTJ=2G:]FWHO1G2^)M7N-(AL7MPA,]VD+;AGY3FM*_P!3LM+B$M[<)"IZ;CR?
MH*X7Q&^OL-,&K16RP_;H]IB.3NY_IFI9[Y9/'.H2W.GSWRVBK'#&BY$>1DDC
MWKH6%3A'YMVZZHY'CI1J2W5VDKK;1MNWR.MT_7]+U24Q6EVCRCG8>#^1JQ?Z
ME9Z9");RX2%3P-QY/T%<1KMS+?\ V:YT_0KNWOK>5720(!D=P<5J:PVFP^)X
M;N\:6[N1#B&Q1-VS_:_G4/#1NM];Z;O3^MS58V?+):736NJ6OD]=.QM6/B/2
MM1G\BVNU:4]$8$$_3-4&U:>+QO-92S!;&.Q\]@1T(/)S]*P/$UU/,FGW*Z0U
MCY=Y'LF? <D]@!V_PK5VJ_Q-E1P&5M-P0>A&ZK5"$4Y=T^SVL9O%5)M0OJI1
MUU5[WZ,?;>--/DUN]AEO(5LHT3R9#GYV/WJFN=9DC\7V=N+A5T^2Q:=L].IP
M<_3%4=+TZR?QOKD+6L1B2.':A48&5YQ3=7L(+WXA:9;2K^X6R)*#HP!; ^G2
MG[.CSV2^S?\ #\Q>UQ'L[MJ_/;K_ #6^XW;7Q1HUY="VAOHVE8X4'(W?2M>N
M0\=Z;:)X9ENXH$CGMF1HW1<$?,!_6K']KW?]^L'0C."G3\]_E_F=*Q4Z=1TZ
MW2ST\[_Y'G<OPU\5Q:S=7UC/#"TDTCHZ38;:S$_RJ1/A9XDU6\1]9U)-@X+F
M0R,%]!7L]%<MSNL>3W_PWU35?%\,]R(5T>%HX402?,((Q@#ZG'ZUN:M\+="F
MTFZ33K7R;TQGR7+G ;MGVKO**0SR?2_AMJTOAB]T75)(8QYRW-G*C;MDF"&!
M]B,5@?\ "L_&$:-9H4^S,<D"XPA]\5[O13N*QPWAWX=6VF^%+_2[Z42SZBN)
MY$'"X^Z%^AY^M<9%\//&>@7<IT:Z38_!DBE"[AVR#7ME%*X['EWA'X<:E;>(
M4US7[A6FB<RK&K;F9^S,?:H/%?POOYM:EU30)4'G2&5HB^PHYY)4^F>:]8HH
MN%CQ*#X8>*=7O8VUB[$<8X,DDOF,!["NG\:^ KO4])T33M$6)8=/5T(D?'!"
MX/UX->C447"QB:/I=S8^#+72IMOVF.S\EL'C=MQUKDOAQX(U?POJMU<ZCY/E
MRVXC7RWR<[@:](HH *P=!TJZT_5-:N)PHCN[GS(L'.1SU_.MZBKC-QBXKJ9S
MI1E*,WO'_*Q@^*-*NM6@L$M0I,%VDS[CCY1G-5M2TC4[/77UG1?+=YD"7%O(
M<!\="#ZUT]%:0Q$XI1Z:_B95,)"<G)WN[?*W8Y4VWB+6;NW^VA-.LXGWNL,F
M7DQVSZ4R\TS5]/\ %5QK&G6\5W'<QJCQN^TI@ <?E76T52Q,D]$K6M;^M2'@
MXM:R=[WOU_R_ XW5=#UK7(H;B[\J.6*9&BMD?Y47/S$GN<5J+I5T/&[:KA?L
MIM/)!SSNSGI6]12>)FURZ6U7WC6#IJ7-=MW3^:_X<Y74=)UFT\13ZMHQ@?[3
M&J2QRG'*\ _I5HZ7?2^++#5)%01QV1BEPW1SD\>W-=!12^L2M:RVM\A_5()M
MW>][=+[F-XITZXU;P[<V5J%,TFW:&.!PP/\ 2J?]BWG]U/\ OJNEHI0KRC'E
M0ZF%A.?.][6^Z_\ F%%%%8G2%%%% !1110 4444 %%%% !1110 4444 %%%%
8 !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g189409g96g40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g189409g96g40.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M&7SI0=6%1W1TOAK4SJNAVUT_^L9,/]02,_I7'B:7L:CB>G@:_MZ*F<+\:?\
MD&Z3_P!=7_D*YT=C.9T'QIH&EZ#;6-YH NKB(,&E(7YLL2/T- &5X7D-W\0K
M2ZLH#;P_:O-*J>(H\DD$^F.*8$.L/=>,/&UVUA&TTEQ*1"H_N*,#]!0!>UKP
MUXR:P-SJL4TMO;*7^=P=@[G\J0$NGRW/B'X=7>D(N^?2)5NHP.2T9W!@/IDT
MQ#/!/CMO",%U;O:FXBG8. &QM;&/RZ4 4X&O/&?CM+A83ON;A7=5Y$: @?D
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M*-&"A$CU+2K35$A6[B\P0OO7G&#3IU94[\O4FM0A624UL&HZ39ZK;B"\@$J
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/JG4E4?-(FE2A1CRP/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>d189409d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bhc-20210524.xsd" xlink:type="simple"/>
    <context id="duration_2021-05-24_to_2021-05-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885590</identifier>
        </entity>
        <period>
            <startDate>2021-05-24</startDate>
            <endDate>2021-05-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-05-24_to_2021-05-24"
      id="Hidden_dei_EntityCentralIndexKey_duration_2021-05-24_to_2021-05-24">0000885590</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="duration_2021-05-24_to_2021-05-24"
      id="Hidden_dei_DocumentFiscalYearFocus_duration_2021-05-24_to_2021-05-24">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="duration_2021-05-24_to_2021-05-24"
      id="Hidden_dei_DocumentFiscalPeriodFocus_duration_2021-05-24_to_2021-05-24">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="duration_2021-05-24_to_2021-05-24"
      id="Hidden_dei_AmendmentFlag_duration_2021-05-24_to_2021-05-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2021-05-24_to_2021-05-24">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-05-24_to_2021-05-24">2021-05-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-05-24_to_2021-05-24">Bausch Health Companies Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-05-24_to_2021-05-24">A1</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressCountry contextRef="duration_2021-05-24_to_2021-05-24">CA</dei:EntityAddressCountry>
    <dei:EntityFileNumber contextRef="duration_2021-05-24_to_2021-05-24">001-14956</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-05-24_to_2021-05-24">98-0448205</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-05-24_to_2021-05-24">2150 St. Elz&#xe9;ar Blvd. West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-05-24_to_2021-05-24">Laval</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-05-24_to_2021-05-24">QC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="duration_2021-05-24_to_2021-05-24">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-05-24_to_2021-05-24">H7L 4A8</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-05-24_to_2021-05-24">514</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-05-24_to_2021-05-24">744-6792</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-05-24_to_2021-05-24">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-05-24_to_2021-05-24">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-05-24_to_2021-05-24">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-05-24_to_2021-05-24">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-05-24_to_2021-05-24">Common Shares, No Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-05-24_to_2021-05-24">BHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-05-24_to_2021-05-24">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-05-24_to_2021-05-24">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140309954533992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 24, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 24,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bausch Health Companies Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2150 St. Elz&#233;ar Blvd. West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Laval<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">QC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">H7L 4A8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0448205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">744-6792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, No Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M4]<![B^4LB\-]_6@_/@S^ 902P,$%     @ @(VX4I^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ @(VX4@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "
MC;A2%@2C4N\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " " C;A2F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ("-N%)A9/#
M=00   @2   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " " C;A2GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"   9%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d189409d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d189409d8k.htm">d189409d8k.htm</File>
    <File>bhc-20210524.xsd</File>
    <File>bhc-20210524_lab.xml</File>
    <File>bhc-20210524_pre.xml</File>
    <File>d189409dex991.htm</File>
    <File>d189409dex992.htm</File>
    <File>d189409dex993.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d189409d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d189409d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bhc-20210524_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bhc-20210524_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bhc-20210524.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "bhc",
   "nsuri": "http://www.bauschhealth.com/20210524",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d189409d8k.htm",
      "contextRef": "duration_2021-05-24_to_2021-05-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d189409d8k.htm",
      "contextRef": "duration_2021-05-24_to_2021-05-24",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.bauschhealth.com//20210524/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-21-171149-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-171149-xbrl.zip
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M7UQ\!:X\=@'72[8_<LEL.Z[:K8M6-S)9[^1JI]GQ\ZWY +*/?P!02P,$%
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M;-6:78_:.!2&[ROU/WC3FUUI0PC,M L:6B%F9H5V/A#0_;JI3'( :QT[LLT
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M;6D<Y[%A ]OU6<2,&5?A&/4:*/^F1G0\G_9S9I@'-E TPZNFFF!6CEM\CK*
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M?ASED<^;I"K)4P]\JS_#(^U0$^W[4X,#M<F(RL,6@(_H6PGTG01NZQ+8KTN
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M%KI#L<'9Q3Z$[1(>ORP7A+NFF:&D&,\*T=C4/%39DU)175=4N6#;K*3O611
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ME9*U=DT/./@E4$*OYPCSVS:+74>]#WY!),M"E\(LO*(Z8Z[NJ\>8Y4Z4>YX
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MYLV;?Y4JZTJ5=W^^5,&$NZNO&.1_<?F_4$L#!!0    ( ("-N%+C7UE5$Q
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M;C6[W<)T;[X=B@;D/_"JS*O/;1G))0LYAJ][*EAXI-S4P:MV&OR4: *"(>V
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MR7FLB!!M;0Y!;^+BJ]?!X[AH9])#SCVVSYF:593BN@T0BW2@LS+.UYWDN?.
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M;AI8D@,'.]ZFW2H[_?4-E8R1U\5CE7HK1_(>%+8'S$7N6>C?R1$'N^ABGG3
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M%-EY&HAL=QX+(EME$)E?;G_K EM_U@*K?_Z;+/826*"S  J4T4M%0^W.?9F
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ME,/9<EVEL1,0<KTV%\!7'K]DF=_#$JV+<EVVXZ0.3XYH3O>I<JG7',$DPA>
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MV[GI+#;O,CZ*.(UQAUBF9"B65%>/RB_H%D')#ABG<PTI/?9JES(5'4#@"#-
MI;(H1%/^WJ_P5K_2Z=6K5_]DJLLRU>VOSU3AAJNS3W"1_L\\_P]02P$"% ,4
M    " " C;A2J?)WV"(#  #3"@  $               @ $     8FAC+3(P
M,C$P-3(T+GAS9%!+ 0(4 Q0    ( ("-N%+)US %V08  /),   4
M      "  5 #  !B:&,M,C R,3 U,C1?;&%B+GAM;%!+ 0(4 Q0    ( ("-
MN%+9]RG<ZP0  #@P   4              "  5L*  !B:&,M,C R,3 U,C1?
M<')E+GAM;%!+ 0(4 Q0    ( ("-N%(+\3G)IQ0  %>.   .
M  "  7@/  !D,3@Y-# Y9#AK+FAT;5!+ 0(4 Q0    ( ("-N%+=ZQK+E1$
M '@Y   1              "  4LD  !D,3@Y-# Y9&5X.3DQ+FAT;5!+ 0(4
M Q0    ( ("-N%+C7UE5$Q   /4T   1              "  0\V  !D,3@Y
M-# Y9&5X.3DR+FAT;5!+ 0(4 Q0    ( ("-N%+#X2XY.!@  *!G   1
M          "  5%&  !D,3@Y-# Y9&5X.3DS+FAT;5!+!08     !P ' +L!
(  "X7@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
